Saltar al contenido
Merck

Saltar a

N2133

Neuraminidase from Clostridium perfringens (C. welchii)

Type X, lyophilized powder, ≥50 units/mg protein (using 4MU-NANA)

Sinónimos:

Acyl-neuraminyl Hydrolase, Receptor-destroying enzyme, Sialidase

Iniciar sesión para ver los precios por organización y contrato.

Seleccione un Tamaño

Cambiar Vistas
Talla/SKUDisponibilidadPrecio
1 unit
Póngase en contacto con nuestro Servicio de Atención al Cliente para disponibilidad
222,00 €
5 units
Póngase en contacto con nuestro Servicio de Atención al Cliente para disponibilidad
773,00 €
657,05 €
10 units
Póngase en contacto con nuestro Servicio de Atención al Cliente para disponibilidad
1320,00 €
1122,00 €
50 units
Póngase en contacto con nuestro Servicio de Atención al Cliente para disponibilidad
4420,00 €
3757,00 €

Acerca de este artículo

Número CAS:
UNSPSC Code:
12352204
NACRES:
NA.54
EC Number:
232-624-6
MDL number:
Número CE:
Specific activity:
≥50 units/mg protein (using 4MU-NANA)

222,00 €


Póngase en contacto con nuestro Servicio de Atención al Cliente para disponibilidad

​
Servicio técnico
¿Necesita ayuda? Nuestro equipo de científicos experimentados está aquí para ayudarle.
Permítanos ayudarle


type

Type X

Quality Segment

form

lyophilized powder

specific activity

≥50 units/mg protein (using 4MU-NANA)

storage temp.

−20°C

Gene Information

Clostridium perfringens str. 13 ... nanI(988807)

General description

Neuraminidase enzymes are glycoside hydrolase enzymes that catalyze hydrolysis of terminal sialic acid residues. The most well-known are the viral nearamidases, which promote influenza virus release.

Application

Neuraminidase from Clostridium perfringens has been used in a study to assess purification via affinity chromatography. It has also been used in a study to investigate site-directed mutations of amino acids of the neuraminidase gene, nanH.

Biochem/physiol Actions

Neuraminidase can block attachment of type 3 reovirus to cell membranes. This effect is related to the ability of neuraminidase to hydrolysis sialic acid residues within cell surface receptors.
Neuraminidase cleavage of sialic acid groups has been used to study recognition by antibodies of glycoprotein structures. The use of neuraminidase in the estimation of N-acetylneuraminic acid was compared favorably to two other methods.
Neuraminidases are used to cleave terminal N-acetyl neuraminic acid (sialic acid) from a variety of glycoproteins. The enzyme from Clostridium perfringens cleaves terminal sialic acid residues which are α-2,3- α-2,6- or α-2,8-linked to Gal, GlcNac, GalNAc, AcNeu, GlcNeu, oligosaccharides, glycolipids or glycoproteins. The relative rate of cleavage decreases in the order: α-2-3 > α-2-6 . α-2-8. Neuraminidase from C. perfringens cleaves α-2-3 linked sialic acid residues most efficiently, compared to A. ureafaciens, (Sigma N3642) which preferentially cleaves α-2-6 linked residues.
The use of neuraminidase to remove sialic acid residues from glycoproteins on cell surfaces has been frequently reported. Generally, procedures have indicated using neuraminidase in PBS at 37°C for 30 minutes, followed by several washings with PBS. Treatment of tissue sections with neuraminidase at much lower concentrations require longer incubation: for 1-4 U/mL in 0.1 M acetate buffer pH 4.2-5, from 2 to 20 hours at 37 °C.

Preparation Note

Purified by affinity chromatography from Type VIII (N 5631)

Analysis Note

Package sizes based on 4MU-NANA units
Package sizes based on the 4MU-NANA units

Other Notes

One unit will hydrolyze 1.0 micromole of 2′-(4-Methylumbelliferyl)-alpha-D-N-actetylneuraminic acid per min at pH 5.0 at 37 °C.

Comparar elementos similares

Ver comparación completa

Mostrar Diferencias

1 of 1

Este artículo
N2876N5254N6514
description

Type X, lyophilized powder, ≥50 units/mg protein (using 4MU-NANA)

description

Suitable for manufacturing of diagnostic kits and reagents, Type V, lyophilized powder

description

Type VI-A, ammonium sulfate suspension

description

Type II, buffered aqueous solution, 8-24 units/mg protein (Lowry, using NAN-lactose)

Gene Information

Clostridium perfringens str. 13 ... nanI(988807)

Gene Information

Clostridium perfringens str. 13 ... nanI(988807)

Gene Information

-

Gene Information

-

specific activity

≥50 units/mg protein (using 4MU-NANA)

specific activity

≥1.3 units/mg solid (using 4MU-NANA), ≥0.1 units/mg solid (using mucin)

specific activity

20-60 units/g agarose

specific activity

8-24 units/mg protein (Lowry, using NAN-lactose)

form

lyophilized powder

form

lyophilized powder

form

ammonium sulfate suspension

form

buffered aqueous solution

storage temp.

−20°C

storage temp.

−20°C

storage temp.

2-8°C

storage temp.

2-8°C

Quality Level

200

Quality Level

300

Quality Level

200

Quality Level

200

type

Type X

type

Type V

type

Type VI-A

type

Type II


Still not finding the right product?


pictograms

Health hazard

signalword

Danger

hcodes

Hazard Classifications

Resp. Sens. 1

Clase de almacenamiento

11 - Combustible Solids

wgk

WGK 1

flash_point_f

Not applicable

flash_point_c

Not applicable

ppe

Eyeshields, Gloves, type N95 (US)



Elija entre una de las versiones más recientes:

Certificados de análisis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documentos section.

Si necesita más asistencia, póngase en contacto con Atención al cliente

¿Ya tiene este producto?

Encuentre la documentación para los productos que ha comprado recientemente en la Biblioteca de documentos.

Visite la Librería de documentos



Preguntas

Revisiones

Sin puntuación

Filtros activos